The C-Peptide response to a standard mixed meal in a group of Brazilian type 1 diabetic patients

被引:11
作者
Pozzan, R [1 ]
Dimetz, T [1 ]
Gazzola, HM [1 ]
Gomes, MB [1 ]
机构
[1] UNIV ESTADO RIO DE JANEIRO, DEPT MED INTERNA, LAB ENDOCRINOL, DISCIPLINA DIABET, RIO DE JANEIRO, BRAZIL
关键词
type 1 diabetes mellitus; C-peptide response; mixed meal test; beta cell function;
D O I
10.1590/S0100-879X1997001000005
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In order to analyze the different parameters used in the interpretation of C-peptide response in a functional test, we compared a group of 26 type 1 diabetics aged 21.1 +/- 8.2 years, with a diabetes duration of 7.9 +/- 6.7 months, with a group of 24 non-diabetic subjects aged 25.0 +/- 4.4 years. A standard mixed meal of 317 kcal was used as a stimulus. Blood sampling for C-peptide determinations was performed at regular intervals. Although all the studied C-peptide variables were significantly lower in the diabetic group (P<0.0001), some overlapping of parameters was observed between the two groups. The highest degree of overlapping was found for basal value (BV) (30.8%) and percent increase (42.31%), and the lowest for incremental area, absolute increase, peak value (PV) (3.8%), and total area (7.7%) (chi(2) = 31.6, P<0.0001). We did not observe a definite pattern in the time of maximum response among the 21 diabetics who showed an increase in C-peptide levels after the stimulus. In this group, however, there was a highly significant number of late responses (120 min) (chi(2) = 5.7, P<0.002). Although BV showed a significant correlation with PV (r(S) = 0.95, P<0.0001), the basal levels of C-peptide did not differentiate the groups with and without response to the stimulus. We conclude that the diabetic group studied showed delayed and reduced C-peptide responses, and that the functional test can be an important tool for the evaluation of residual beta cell function.
引用
收藏
页码:1169 / 1174
页数:6
相关论文
共 23 条
[1]   PLASMA-C-PEPTIDE LEVELS AND CLINICAL REMISSIONS IN RECENT-ONSET TYPE-I DIABETIC-PATIENTS TREATED WITH CYCLOSPORINE-A AND INSULIN [J].
ASSAN, R ;
FEUTREN, G ;
SIRMAI, J ;
LABORIE, C ;
BOITARD, C ;
VEXIAU, P ;
DUROSTU, H ;
RODIER, M ;
FIGONI, M ;
VAGUE, P ;
HORS, J ;
BACH, JF .
DIABETES, 1990, 39 (07) :768-774
[2]   RESIDUAL BETA-CELL FUNCTION IN CHILDREN WITH IDDM - REPRODUCIBILITY OF TESTING AND FACTORS INFLUENCING INSULIN SECRETORY RESERVE [J].
CLARSON, C ;
DANEMAN, D ;
DRASH, AL ;
BECKER, DJ ;
EHRLICH, RM .
DIABETES CARE, 1987, 10 (01) :33-38
[3]   METABOLIC CONTROL IN 131 JUVENILE-ONSET DIABETIC-PATIENTS AS MEASURED BY HBA1C - RELATION TO AGE, DURATION, C-PEPTIDE, INSULIN DOSE, AND ONE OR 2 INSULIN INJECTIONS [J].
DAHLQUIST, G ;
BLOM, L ;
BOLME, P ;
HAGENFELDT, L ;
LINDGREN, F ;
PERSSON, B ;
THALME, B ;
THEORELL, M ;
WESTIN, S .
DIABETES CARE, 1982, 5 (04) :399-403
[4]  
DCCT Res Grp, 1987, J CLIN ENDOCR METAB, V65, P30
[5]   B-CELL FUNCTION AND BLOOD-GLUCOSE CONTROL IN INSULIN DEPENDENT DIABETICS WITHIN FIRST MONTH OF INSULIN-TREATMENT [J].
FABER, OK ;
BINDER, C .
DIABETOLOGIA, 1977, 13 (03) :263-268
[6]  
FRIER BM, 1977, DIABETES, V26, P369
[7]   CORRELATION BETWEEN MINIMAL SECRETORY CAPACITY OF PANCREATIC BETA-CELLS AND STABILITY OF DIABETIC CONTROL [J].
FUKUDA, M ;
TANAKA, A ;
TAHARA, Y ;
IKEGAMI, H ;
YAMAMOTO, Y ;
KUMAHARA, Y ;
SHIMA, K .
DIABETES, 1988, 37 (01) :81-88
[8]   CORRELATION BETWEEN FASTING SERUM C-PEPTIDE AND B-CELL INSULIN SECRETORY CAPACITY IN DIABETES-MELLITUS [J].
GARCIAWEBB, P ;
BONSER, A ;
WELBORN, TA .
DIABETOLOGIA, 1982, 22 (04) :296-296
[9]   CORRELATIONS BETWEEN FASTING PLASMA C-PEPTIDE, GLUCAGON-STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN INSULIN-TREATED DIABETICS [J].
GJESSING, HJ ;
MATZEN, LE ;
FROLAND, A ;
FABER, OK .
DIABETES CARE, 1987, 10 (04) :487-490
[10]  
HARRIS M, 1979, DIABETES, V28, P1039